MA16.03 CRISPR Screen Reveals XPO1 as a Therapeutic Target Strongly Sensitizing to First and Second Line Therapy in Small Cell Lung Cancer

Authors :: Yingqian Zhan
Joseph M. Chan
E. De Stanchina
Fathema Uddin
Andrew Chow
Jacklynn V. Egger
U. Bhanot
Viola Allaj
Álvaro Quintanal-Villalonga
Triparna Sen
John T. Poirier
Michael Offin
Yuan Hao
Hirokazu Taniguchi
P. Manoj
Shweta S. Chavan
Charles M. Rudin
J. Qiu
Nisargbhai S. Shah
Source :: Journal of Thoracic Oncology. 16:S938
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Pulmonary and Respiratory Medicine
Second-line therapy
XPO1
Oncology
business.industry
Cancer research
Medicine
CRISPR
Non small cell
business

Full Text Access

Tools